Senior insider sale
President & CEO at LYRA THERAPEUTICS, INC. — senior position signals high conviction
$3.5K
39.57K shares
What this filing means
PALASIS MARIA plans to sell 39.57K shares of LYRA THERAPEUTICS, INC. valued at approximately $3.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/9/2025ACC: 0001959173-25-002561
DirectorOfficer· President & CEO
Since Apr 2020
39.57K
Shares to sell
$3.5K
Approx. market value
39.57K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
4/1/2025
39.57KTotal acquired39.57K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2025 | Restricted Stock Vesting Compensation | 39.57K | — |
| Total | 39.57K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
39.57K
Market value
$3.5K
4/9/2025
Total
Units
39.57K
Value
$3.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/9/2025 | 39.57K | $3.5K | NASDAQ | Planned |
| Total | 39.57K | $3.5K | ||